Expand ABT Menu
ABT MENU

ABT Latest Press Releases

-- June 8, 2026 --

New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers PRNewswire 9:00 AM

-- June 6, 2026 --

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis PRNewswire 9:00 AM

-- May 27, 2026 --

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes PRNewswire 9:00 AM
ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening PRNewswire 7:01 AM

-- May 26, 2026 --

Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026 PRNewswire 9:00 AM

-- April 28, 2026 --

Abbott receives FDA clearance and CE Mark for next-generation Ultreon 3.0 AI-powered coronary imaging platform PRNewswire 9:00 AM

-- April 25, 2026 --

Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026 PRNewswire 12:30 PM

-- April 17, 2026 --

New data at AACR 2026 demonstrate advancements in Cancerguard Multi-Cancer Early Detection Test PRNewswire 3:30 PM

-- April 16, 2026 --

Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences PRNewswire 7:30 AM

-- April 9, 2026 --

New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health PRNewswire 9:00 AM

-- March 30, 2026 --

Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR platform PRNewswire 9:00 AM

-- March 26, 2026 --

Abbott hosts conference call for first-quarter earnings PRNewswire 9:00 AM

-- March 24, 2026 --

John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard tests, encouraging colon cancer screening PRNewswire 8:00 AM

-- March 23, 2026 --

Abbott completes acquisition of Exact Sciences PRNewswire 8:50 AM

-- March 20, 2026 --

Abbott acquisition of Exact Sciences set to close on March 23, 2026 PRNewswire 9:00 AM

-- March 12, 2026 --

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management PRNewswire 8:00 AM

-- March 11, 2026 --

Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team' PRNewswire 11:00 AM

-- March 5, 2026 --

Trial Set in NEC Multidistrict Litigation Against Reckitt Benckiser's Mead Johnson Led by Levin Papantonio Business Wire 6:19 AM

-- February 20, 2026 --

Exact Sciences Stockholders Approve Acquisition by Abbott Business Wire 4:05 PM
Abbott declares 409th consecutive quarterly dividend PRNewswire 11:39 AM

-- February 6, 2026 --

Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation PRNewswire 8:00 AM

-- January 22, 2026 --

Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook PRNewswire 7:30 AM

-- January 20, 2026 --

Abbott receives CE Mark for the TactiFlex Duo Ablation Catheter to treat patients with abnormal heart rhythms PRNewswire 9:00 AM

-- January 16, 2026 --

Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS PRNewswire 2:02 PM
Market Data Delayed 15 Minutes